The World Health Organization (WHO) has suspended testing of the drug hydroxychloroquine in Covid-19 patients due to safety concerns. This was conveyed by WHO Director General Tedros Adhanom Ghebreyesus in an online briefing held Monday, May 25, 2020.
“The executive group has temporarily suspended hydroxychloroquine testing in the Solidarity trial. While safety data is being reviewed by the data security monitoring board. Tedros was quoted as saying by Reuters on Monday.
Previously, Hydroxycholoroquine has been praised by United States President Donald Trump and others as a treatment that might cure diseases caused by the new corona virus. Trump also briefly claimed that he used the drug to help prevent infections.
Tedros explained the temporary suspension of the trial was the main initiative to conduct clinical trials of potential treatment for the virus. WHO previously recommended not to use hydroxychloroquine in treating or preventing corona virus infections, except as part of clinical trials.
Dr. Mike Ryan, head of the WHO emergency program, said the decision to postpone the hydroxychloroquine trial had been taken, “with caution,” Ryan said.
An earlier study of more than 300 male patients at Veterans Health Administration medical centers across the country also found higher mortality rates for those using hydroxychloroquine. And the American food and drug agency (FDA) warned in April not to use the drug outside of hospitals and clinical trials. She New York Post was quoted as saying.